Why the study?
Do haemostatic activation markers differ between various subtypes and phases of ischaemic stroke?
Population
161 individuals, comprising 138 patients with ischaemic stroke and 23 age-matched controls.
Design
Cohort
Follow-up
Up to chronic phase (≥ 29 days after onset)
Authors
Loading...
May aid cardioembolic subtype identification; hypothesis-generating and should not yet change practice.
Do haemostatic activation markers differ between various subtypes and phases of ischaemic stroke?
Haemostatic markers of coagulation and fibrinolysis are significantly altered in cardioembolic stroke compared to other subtypes, suggesting their potential utility in detecting intracardiac thrombin and plasmin generation.
Yamazaki et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: